Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

por Vakrou, Styliani, Liu, Yamin, Zhu, Li, Greenland, Gabriela V., Simsek, Bahadir, Hebl, Virginia B., Guan, Yufan, Woldemichael, Kirubel, Talbot, Conover C., Aon, Miguel A., Fukunaga, Ryuya, Abraham, M. Roselle
Publicado 2021

Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy

por Liu, Yamin, Afzal, Junaid, Vakrou, Styliani, Greenland, Gabriela V., Talbot, C. Conover, Hebl, Virginia B., Guan, Yufan, Karmali, Rehan, Tardiff, Jil C., Leinwand, Leslie A., Olgin, Jeffrey E., Das, Samarjit, Fukunaga, Ryuya, Abraham, M. Roselle
Publicado 2019

Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19

por Bos, J. Martijn, Hebl, Virginia B., Oberg, Ann L., Sun, Zhifu, Herman, Daniel S., Teekakirikul, Polakit, Seidman, Jonathan G., Seidman, Christine E., dos Remedios, Cristobal G., Maleszewski, Joseph J., Schaff, Hartzell V., Dearani, Joseph A., Noseworthy, Peter A., Friedman, Paul A., Ommen, Steve R., Brozovich, Frank V., Ackerman, Michael J.
Publicado 2020